• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[晚期溶栓灌注在急性心肌梗死中的价值]

[The value of late thrombolytic perfusion in acute myocardial infarct].

作者信息

Gulba D C

机构信息

Klinikum Rudolf Virchow, Franz-Volhard-Klinik und Max-Delbrück-Centrum für Molekulare Medizin, Berlin-Buch.

出版信息

Z Kardiol. 1993;82 Suppl 2:183-5.

PMID:8328200
Abstract

Contradicting previous views that reperfusion therapy in acute myocardial infarction has to be restricted to the first 4 to 6 h, the paradigm of thrombolysis in acute myocardial infarction has to be expanded to 12 h, since the results of the LATE study have been published. While early thrombolysis (up to 90 min) aims towards myocardial salvage, the benefit of late reperfusion seems to depend on an improved myocardial remodeling and on rhythmic stabilization (open artery hypothesis). Today the value of late reperfusion therapy can be regarded as proven in a clinical setting, the mechanisms of late reperfusion therapy, however, still remain to be settled.

摘要

与之前认为急性心肌梗死再灌注治疗必须限制在发病后的最初4至6小时的观点相反,急性心肌梗死溶栓治疗的范例必须扩展至12小时,因为LATE研究的结果已经公布。早期溶栓(至90分钟)旨在挽救心肌,而晚期再灌注的益处似乎取决于改善心肌重构和节律稳定(开放动脉假说)。如今,晚期再灌注治疗在临床环境中的价值已被视为得到证实,然而,晚期再灌注治疗的机制仍有待确定。

相似文献

1
[The value of late thrombolytic perfusion in acute myocardial infarct].[晚期溶栓灌注在急性心肌梗死中的价值]
Z Kardiol. 1993;82 Suppl 2:183-5.
2
[New substances and dosages for thrombolysis in acute myocardial infarct].[急性心肌梗死溶栓治疗的新物质与剂量]
Z Kardiol. 1993;82 Suppl 2:137-41.
3
Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.代谢综合征对急性心肌梗死溶栓治疗后冠状动脉通畅情况的影响。
Coron Artery Dis. 2009 Sep;20(6):387-91. doi: 10.1097/MCA.0b013e328330d557.
4
[Thrombolysis in acute myocardial infarct: prerequisites, current experiences and remaining problems].[急性心肌梗死的溶栓治疗:前提条件、当前经验及遗留问题]
Schweiz Med Wochenschr. 1986 Aug 16;116(33):1074-87.
5
Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.与链激酶相比,rt-PA溶栓治疗后纤溶酶原激活物抑制剂-1水平与梗死相关冠状动脉通畅情况的关系。
Thromb Haemost. 1999 Jul;82(1):104-8.
6
[Late thrombolysis in the therapy of acute myocardial infarct: the prospects for its wide-spread clinical use].[急性心肌梗死治疗中的晚期溶栓:其广泛临床应用的前景]
Cardiologia. 1991 Dec;36(12 Suppl 1):435-41.
7
[The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].急性心肌梗死全身挽救性溶栓治疗的安全性与有效性
Ital Heart J Suppl. 2000 Jan;1(1):81-7.
8
Thrombolysis in the management of acute myocardial infarction. Current status and future perspectives.急性心肌梗死治疗中的溶栓疗法。现状与未来展望。
Rev Port Cardiol. 1998 Dec;17(12):959-65.
9
Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.急性心肌梗死中加速输注链激酶可使梗死相关动脉获得更好的心肌梗死溶栓治疗(TIMI)血流分级。
Indian Heart J. 2000 Jan-Feb;52(1):40-4.
10
The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
Z Kardiol. 1993;82 Suppl 2:195-200.